Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults

Trial Profile

Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Jun 2015

At a glance

  • Drugs Immunoglobulin G (Primary)
  • Indications Immune thrombocytopenic purpura
  • Focus Therapeutic Use
  • Sponsors Octapharma
  • Most Recent Events

    • 29 Jun 2015 According to an Octapharma media release, data from this study were published in Hematology in October 2010.
    • 15 Jul 2014 Results published in the Octapharma Media Release.
    • 12 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top